This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Diabetes, Metabolic Syndrome And Cardiovascular Disease

Appendix 1: The History of Insulin 215


Figure 2.1: Worldwide Rates of Diabetes Cases, 2012, 2020 and 2030 16

Figure 2.2: Worldwide Prevalence of Diabetes (%) in Adults (20-79 Years), 2011 18

Figure 2.3: Prevalence of Diabetes by Age in the U.S, 2010 19

Figure 2.4: New Adult Cases of Diabetes Diagnosed in the U.S., 2010 20

Figure 2.5: Mean Diabetes Healthcare-related Expenditures Per Adult (20-79 Years) with Diabetes, 2011 21

Figure 2.6: How Diabetes Dollars are Spent in the U.S., 2007 23

Figure 3.1: Maintenance of Normal Blood Sugar Levels 26

Figure 3.2: Obesity (BMI ³ 30) Prevalence in U.S. Adults, 2010 35

Figure 3.3: Percentage of Obese Adults in the U.S., 2009-2010 35

Figure 3.4: Percentage of Obese Children and Adolescents in the U.S., 2009-2010 36

Figure 3.5: Trends in Obesity Among Children and Adolescents in the U.S., 1963-2008 36

Figure 3.6: Annual Death Rate of U.S. Population from Heart Disease, 1950-2008 43

Figure 3.7: Heart Disease Death Rate by Race and Sex in the U.S., 1979-2008 44

Figure 3.8: Annual Death Rate of U.S. Population from Strokes, 1950-2008 44

Figure 3.9: U.S. Male and Female Population Death Rates from Strokes, 2008 45

Figure 3.10: Percentage of U.S. Population That Smokes, 1965-2010 46

Figure 3.11: Percentage of Obese Adults in the U.S., 1960-2008 47

Figure 3.12: Percentage of Obese Children and Adolescents in the U.S., 1971-2008 48

Figure 3.13: Number of Annual Prescriptions for Popular Cholesterol Drugs, 2006-2010 51

Figure 4.1: Top Therapeutic Classes Contributing to Growth in U.S. Drug Spending, 2010-2011 68

Figure 4.2: Top Ten Diabetes Medications in the U.S., by Number of Prescriptions 69

Figure 4.3: U.S. Non-Insulin Anti-Diabetic Drug Prescriptions, 2010 69

Figure 5.1: Comparison of the Effects of the Pioglitazone and Rosiglitazone on Lipids 81

Figure 5.2: Overview of GLP-1 and Blood Glucose 84

5 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 0.00%
GOOG $695.70 0.00%
FB $118.06 0.00%
TSLA $222.56 0.00%
YHOO $36.00 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs